EA201390980A1 - DRUG PLASTER FOR IMPROVED TRANSDERMAL PENETRATION OF DICLOFENAC DIETHYLAMMONIUM - Google Patents

DRUG PLASTER FOR IMPROVED TRANSDERMAL PENETRATION OF DICLOFENAC DIETHYLAMMONIUM

Info

Publication number
EA201390980A1
EA201390980A1 EA201390980A EA201390980A EA201390980A1 EA 201390980 A1 EA201390980 A1 EA 201390980A1 EA 201390980 A EA201390980 A EA 201390980A EA 201390980 A EA201390980 A EA 201390980A EA 201390980 A1 EA201390980 A1 EA 201390980A1
Authority
EA
Eurasian Patent Office
Prior art keywords
transdermal penetration
improved transdermal
diclofenac diethylammonium
drug
plaster
Prior art date
Application number
EA201390980A
Other languages
Russian (ru)
Inventor
Франческо Чилурцо
Паола Мингетти
Original Assignee
Фармафилм С.Р.Л.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармафилм С.Р.Л. filed Critical Фармафилм С.Р.Л.
Publication of EA201390980A1 publication Critical patent/EA201390980A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Лекарственный пластырь для улучшенного трансдермального проникновения диклофенака диэтиламмония в композиции, содержащей акриловый сополимер и сложный эфир лимонной кислоты.Drug patch for improved transdermal penetration of diclofenac diethylammonium in a composition containing acrylic copolymer and citric acid ester.

EA201390980A 2010-12-29 2010-12-29 DRUG PLASTER FOR IMPROVED TRANSDERMAL PENETRATION OF DICLOFENAC DIETHYLAMMONIUM EA201390980A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2010/070882 WO2012089256A1 (en) 2010-12-29 2010-12-29 Medicated patch for improved transdermal permeation of diclofenac diethylammonium

Publications (1)

Publication Number Publication Date
EA201390980A1 true EA201390980A1 (en) 2013-11-29

Family

ID=44624959

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201390980A EA201390980A1 (en) 2010-12-29 2010-12-29 DRUG PLASTER FOR IMPROVED TRANSDERMAL PENETRATION OF DICLOFENAC DIETHYLAMMONIUM

Country Status (5)

Country Link
EP (1) EP2658576A1 (en)
CN (1) CN103384533A (en)
BR (1) BR112013016998A2 (en)
EA (1) EA201390980A1 (en)
WO (1) WO2012089256A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3028436A1 (en) 2016-06-23 2017-12-28 Corium International, Inc. Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
AU2017301928B2 (en) 2016-07-27 2023-04-06 Corium, LLC. Donepezil transdermal delivery system
WO2019126531A1 (en) 2017-12-20 2019-06-27 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
IT202000011686A1 (en) * 2020-05-20 2021-11-20 Fidia Farm Spa SLOW RELEASE MEDICATED PATCH

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61280426A (en) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk Anti-inflammatory and analgesic application agent
KR19990026792A (en) * 1997-09-26 1999-04-15 김윤 Matrix Patches Containing Diclofenac Diethylammonium Salt
DE29823343U1 (en) * 1998-03-20 1999-07-15 Schwarz Pharma Ag, 40789 Monheim Transdermal therapeutic system (TTS) containing oxybutynin

Also Published As

Publication number Publication date
CN103384533A (en) 2013-11-06
BR112013016998A2 (en) 2016-10-25
EP2658576A1 (en) 2013-11-06
WO2012089256A1 (en) 2012-07-05

Similar Documents

Publication Publication Date Title
CY1120888T1 (en) TRANSPARENT PHARMACEUTICAL COMPOSITIONS INCLUDING ACTIVE AGENTS
UA113620C2 (en) COMPOSITION CONTAINING AMORPHINE (5-FLUORO-2-METHYL-3-QUINOLIN-2-ILMETHYLINDOL-1-IL) ACETIC ACID
UA122324C2 (en) THERAPEUTICALLY ACTIVE COMPOUNDS AND METHODS OF THEIR APPLICATION
DK3384903T3 (en) Microparticle-containing therapeutic protein coated with biodegradable polymer for medical use
EA201290880A1 (en) NEW CONNECTIONS - ENZYME INHIBITORS
MX342951B (en) Therapeutically active compositions and their method of use.
EA201201657A1 (en) TREATMENT OF DIABETES
BR112015000561A2 (en) irak inhibitors and uses thereof
EA201291357A1 (en) TREATMENT METHODS USING TLR7 AND / OR TLR9 INHIBITORS
MX2015008286A (en) Multi-polymer compositions for transdermal drug delivery.
DK2651410T3 (en) Transdermal therapeutic system for administering an active substance
EP2654638A4 (en) Composition for transdermal administration of non-steroidal anti-inflammatory drug
MX2015008284A (en) Compositions and methods for transdermal delivery of non-steroidal anti-inflammatory agents.
PH12014501240A1 (en) Film containing compositions
CO7240370A2 (en) Pharmaceutical form for prolonged release of active substances
EA201490041A1 (en) PLASTER CONTAINING DICLOFENAC AND THYOKOLCHICOSID
EA201390980A1 (en) DRUG PLASTER FOR IMPROVED TRANSDERMAL PENETRATION OF DICLOFENAC DIETHYLAMMONIUM
EA201591259A1 (en) SOLID FORMS OF HINAZOLIN DERIVATIVE AND THEIR APPLICATION AS A BRAF INHIBITOR
EA201390950A1 (en) HOMOGENEOUS PHARMACEUTICAL ORAL DOSAGE FORMS CONTAINING LERKANIDIPIN AND ENALAPRIL OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS TOGETHER WITH ORGANIC ACID
CO7111279A2 (en) Stable immediate-release oral pharmaceutical compositions containing prasugrel
EA201390417A1 (en) ANTI-DIABETIC SOLID PHARMACEUTICAL COMPOSITIONS
EA201291276A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING SOLIPHENACINE
CY1122538T1 (en) CHONDROITIN COMPLEXES FOR TRANSCUTANEOUS ABSORPTION
EA201491099A1 (en) CONNECTION, PRESENTING ANTAGONIST LEUCOTRIEN B4
CY1116396T1 (en) NEW COMPOSITION FOR THERAPEUTIC INDIVIDUAL THERAPEUTIC TREATMENT